A British newspaper recently claimed that criminals might be able to manipulate their own DNA to dodge police detection.
The move follows an administration push for cuts to the NSF and raises concerns in the scientific community that it could ...
Zacks Investment Research on MSN
Why the market dipped but CRISPR Therapeutics AG (CRSP) gained today
In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $52.06, marking a +2.1% move from the previous day. This change outpaced the S&P 500's 0.49% loss on the day. Elsewhere, the Dow ...
18h
Milestone for Crispr: First-of-Its-Kind Gene Editing Treatment Successfully Passes Clinical Trial
Intellia Therapeutics, a leading biotechnology company, announced that its CRISPR-based treatment for a rare swelling ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results